Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,615 | 190 | 99.2% |
| Education | $27.60 | 2 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $539.16 | 32 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $472.36 | 24 | $0 (2022) |
| Amgen Inc. | $417.90 | 22 | $0 (2024) |
| PFIZER INC. | $239.15 | 11 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $216.91 | 6 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $185.30 | 7 | $0 (2022) |
| Biohaven Pharmaceutical Holding Company Ltd. | $169.80 | 12 | $0 (2022) |
| GlaxoSmithKline, LLC. | $160.73 | 8 | $0 (2022) |
| Amarin Pharma Inc. | $154.33 | 8 | $0 (2021) |
| Biohaven Pharmaceuticals, Inc. | $139.54 | 10 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $71.00 | 4 | ABBVIE INC. ($19.56) |
| 2023 | $123.60 | 7 | PFIZER INC. ($29.01) |
| 2022 | $498.75 | 29 | Biohaven Pharmaceutical Holding Company Ltd. ($169.80) |
| 2021 | $1,052 | 53 | Novo Nordisk Inc ($183.13) |
| 2020 | $489.14 | 24 | AstraZeneca Pharmaceuticals LP ($130.05) |
| 2019 | $625.52 | 31 | Amgen Inc. ($192.13) |
| 2018 | $411.56 | 18 | Boehringer Ingelheim Pharmaceuticals, Inc. ($131.09) |
| 2017 | $371.01 | 26 | SANOFI-AVENTIS U.S. LLC ($126.49) |
All Payment Transactions
192 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/12/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: NEUROSCIENCE | ||||||
| 02/23/2024 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Bone Health | ||||||
| 01/16/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Biological | ||||||
| 01/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Diabetes | ||||||
| 11/09/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: Urology | ||||||
| 10/20/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $24.18 | General |
| Category: Cardiovascular | ||||||
| 09/23/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Diabetes | ||||||
| 08/18/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: TEPEZZA | ||||||
| 03/13/2023 | PFIZER INC. | COMIRNATY (Biological), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: VACCINES | ||||||
| 03/03/2023 | PFIZER INC. | COMIRNATY (Biological), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: VACCINES | ||||||
| 02/21/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: Diabetes | ||||||
| 11/03/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Diabetes | ||||||
| 10/26/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: PRIMARY CARE | ||||||
| 09/26/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $6.01 | General |
| Category: PRIMARY CARE | ||||||
| 09/01/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $24.46 | General |
| 08/18/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $25.07 | General |
| Category: NEUROSCIENCE | ||||||
| 08/11/2022 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Seglentis | Food and Beverage | Cash or cash equivalent | $23.90 | General |
| Category: Cardiovascular | ||||||
| 08/09/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: Diabetes Care | ||||||
| 08/02/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: PRIMARY CARE | ||||||
| 07/21/2022 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 07/20/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $11.26 | General |
| Category: PRIMARY CARE | ||||||
| 07/15/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: RESPIRATORY | ||||||
| 07/08/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $37.50 | General |
| Category: PRIMARY CARE | ||||||
| 07/08/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 187 | 407 | $60,230 | $34,942 |
| 2022 | 3 | 343 | 1,024 | $155,247 | $88,935 |
| 2021 | 3 | 313 | 1,049 | $160,997 | $94,120 |
| 2020 | 3 | 281 | 1,043 | $162,096 | $76,580 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 120 | 290 | $45,550 | $27,319 | 60.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 67 | 117 | $14,680 | $7,622 | 51.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 238 | 878 | $137,907 | $79,648 | 57.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 90 | 130 | $16,335 | $9,098 | 55.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 15 | 16 | $1,005 | $187.96 | 18.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 254 | 977 | $153,457 | $90,509 | 59.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 36 | 48 | $6,031 | $3,316 | 55.0% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 23 | 24 | $1,508 | $295.44 | 19.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 256 | 1,016 | $159,583 | $75,754 | 47.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 11 | 13 | $1,633 | $632.39 | 38.7% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 14 | 14 | $879.62 | $193.47 | 22.0% |
About Dr. Luis Ragunton, M.D
Dr. Luis Ragunton, M.D is a Internal Medicine healthcare provider based in Aiea, Hawaii. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1598869067.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Luis Ragunton, M.D has received a total of $3,643 in payments from pharmaceutical and medical device companies, with $71.00 received in 2024. These payments were reported across 192 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($3,615).
As a Medicare-enrolled provider, Ragunton has provided services to 1,124 Medicare beneficiaries, totaling 3,523 services with total Medicare billing of $294,576. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Aiea, HI
- Active Since 09/12/2006
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1598869067
Products in Payments
- NURTEC ODT (Drug) $309.34
- FARXIGA (Drug) $300.96
- Ozempic (Drug) $268.91
- EVENITY (Biological) $186.56
- JARDIANCE (Drug) $181.02
- ELIQUIS (Drug) $156.91
- Vascepa (Drug) $154.33
- Victoza (Drug) $133.88
- SOLIQUA (Drug) $113.86
- Repatha (Biological) $112.50
- TRELEGY ELLIPTA (Drug) $99.48
- QULIPTA (Drug) $87.49
- TRULICITY (Drug) $87.16
- Livalo (Drug) $86.09
- Non-Covered Product (Drug) $81.20
- Prolia (Biological) $72.94
- BYDUREON (Drug) $63.68
- Xofluza (Drug) $60.99
- COLOGUARD (Device) $58.98
- RYBELSUS (Drug) $52.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Aiea
Roy Ebisu, Md, MD
Internal Medicine — Payments: $18,765
Stephen Miyasato, Md, MD
Internal Medicine — Payments: $18,084
Dr. Francis Buto, M.d, M.D
Internal Medicine — Payments: $14,868
Dr. Alan Oki, Md, MD
Internal Medicine — Payments: $14,573
Mark Nishihara, M.d, M.D
Internal Medicine — Payments: $14,206
Dr. Malissa Iida-Takashima, Md, MD
Internal Medicine — Payments: $13,761